NanoString Technologies (NanoString Technologies) Operating Income : $-162.6 Mil (TTM As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is NanoString Technologies Operating Income?

NanoString Technologies's Operating Income for the three months ended in Sep. 2023 was $-36.5 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2023 was $-162.6 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. NanoString Technologies's Operating Income for the three months ended in Sep. 2023 was $-36.5 Mil. NanoString Technologies's Revenue for the three months ended in Sep. 2023 was $48.1 Mil. Therefore, NanoString Technologies's Operating Margin % for the quarter that ended in Sep. 2023 was -75.83%.

Warning Sign:

NanoString Technologies Inc operating margin has been in a 5-year decline. The average rate of decline per year is -21.9%.

NanoString Technologies's 5-Year average Growth Rate for Operating Margin % was -21.90% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. NanoString Technologies's annualized ROC % for the quarter that ended in Sep. 2023 was -105.34%. NanoString Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -133.94%.

NanoString Technologies Operating Income Historical Data

The historical data trend for NanoString Technologies's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoString Technologies Operating Income Chart

NanoString Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Income

Get a 7-Day Free Trial

-69.39

-82.70

-88.05

-108.23

-152.18

NanoString Technologies Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Operating Income	Get a 7-Day Free Trial															-34.94	-42.68	-40.55	-42.89	-36.47

NanoString Technologies Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-162.6 Mil.

NanoString Technologies (OTCPK:NSTGQ) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

NanoString Technologies's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

	ROC % (Q: Sep. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Sep. 2023 ))	/ count )
=	-145.868 * ( 1 - 0.13% )	/	( (141.871	+	134.704)	/ 2 )
=	-145.6783716	/	138.2875
=	-105.34 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	288.99	-	29.517	-	( 117.602	-	max(0, 62.433	-	221.445	+	117.602	))
=	141.871

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	274.713	-	42.908	-	( 97.101	-	max(0, 77.532	-	211.807	+	97.101	))
=	134.704

Note: The Operating Income data used here is four times the quarterly (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

NanoString Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Sep. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-142.252	/	( ( (63.397 + max(46.85, 0))	+	(59.411 + max(42.752, 0)) )	/	2 )
=	-142.252	/	( ( 110.247	+	102.163 )	/	2 )
=	-142.252	/	106.205
=	-133.94 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(42.982	+	48.849	+	12.012)	-	(29.517	+	14.366	+	13.11)
=	46.85

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(48.352	+	55.159	+	11.195)	-	(42.908	+	14.501	+	14.545)
=	42.752

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

NanoString Technologies's Operating Margin % for the quarter that ended in Sep. 2023 is calculated as:

Operating Margin %	=	Operating Income (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-36.467	/	48.089
	=	-75.83 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

NanoString Technologies Operating Income Related Terms

Thank you for viewing the detailed overview of NanoString Technologies's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

NanoString Technologies (NanoString Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NanoString Technologies Inc (OTCPK:NSTGQ) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

0F1:Germany

Address

530 Fairview Avenue North, Seattle, WA, USA, 98109

Website

https://www.nanostring.com

NanoString Technologies Inc is engaged in the development, manufacturing and commercialization of instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its core technology includes proprietary chemistries that enable the labeling and counting of single molecules. The firm uses its technology to develop tools for scientific and clinical research, primarily in the fields of genomics and proteomics. It offers two product platforms such as nCounter Analysis System or nCounter, and GeoMx Digital Spatial Profiler or DSP system both include instruments, related consumables, and software. NanoString Technologies generates revenue from the sale of products and related services and collaborations.

Executives

Jonathan Todd Garland	officer: Chief Commercial Officer	C/O CYTEK BIOSCIENCES, INC., 47215 LAKEVIEW BOULEVARD, FREMONT CA 94538
K Thomas Bailey	officer: Chief Financial Officer	1618 STATION STREET, VANCOUVER A1 V6A 1B6
R Bradley Gray	director, officer: President and CEO	530 FAIRVIEW AVENUE NORTH, SUITE 2000, SEATTLE WA 98109
William Young	director	14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Waite Charles P Jr	director, 10 percent owner	11023 NE 116TH STREET, KIRKLAND WA 98034
Gregory Norden	director	16640 CHESTERFIELD GROVE DRIVE, SUITE 200, CHESTERFIELD MO 63005
Elisha W Finney	director	C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Teresa M. Foy	director	530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Joseph M Beechem	officer: SVP, Research & Development	530 FAIRVIEW AVENUE NORTH, SUITE 2000, SEATTLE WA 98109
John D. Gerace	officer: Chief Commercial Officer	C/O NANOSTRING TECHNOLOGIES, INC., 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Kirk Malloy	director	5200 ILLUMINA WAY, SAN DIEGO CA 92122
J. Chad Brown	officer: SVP, Sales & Marketing	530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Robert Hershberg	director	3005 FIRST AVENUE, SEATTLE WA 98121
Janet George	director	530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Dana E. Rollison	director	530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109